Firefly Neuroscience (NASDAQ:AIFF) Major Shareholder Windsor Private Capital Lp Sells 30,126 Shares of Stock

Firefly Neuroscience, Inc. (NASDAQ:AIFF) major shareholder Windsor Private Capital Lp sold 30,126 shares of the business’s stock in a transaction dated Thursday, October 9th. The stock was sold at an average price of $2.94, for a total transaction of $88,570.44. Following the sale, the insider directly owned 1,606,647 shares of the company’s stock, valued at $4,723,542.18. This represents a 1.84% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Windsor Private Capital Lp also recently made the following trade(s):

• On Tuesday, October 14th, Windsor Private Capital Lp sold 29,500 shares of Firefly Neuroscience stock. The stock was sold at an average price of $2.74, for a total value of $80,830.00.
• On Monday, October 13th, Windsor Private Capital Lp sold 32,136 shares of Firefly Neuroscience stock. The stock was sold at an average price of $2.65, for a total value of $85,160.40.
• On Friday, October 10th, Windsor Private Capital Lp sold 74,810 shares of Firefly Neuroscience stock. The stock was sold at an average price of $2.70, for a total value of $201,987.00.

Firefly Neuroscience Stock Performance

Shares of AIFF opened at $2.75 on Wednesday. Firefly Neuroscience, Inc. has a one year low of $1.86 and a one year high of $17.20. The stock has a market capitalization of $36.99 million, a price-to-earnings ratio of -1.10 and a beta of 2.11. The stock has a 50 day moving average price of $2.79 and a 200 day moving average price of $3.00.

Firefly Neuroscience (NASDAQ:AIFF) last issued its quarterly earnings results on Wednesday, August 13th. The company reported ($0.14) EPS for the quarter. Firefly Neuroscience had a negative return on equity of 464.02% and a negative net margin of 5,335.75%.

Institutional Investors Weigh In On Firefly Neuroscience

A hedge fund recently bought a new stake in Firefly Neuroscience stock. FNY Investment Advisers LLC acquired a new stake in Firefly Neuroscience, Inc. (NASDAQ:AIFF) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 22,706 shares of the company’s stock, valued at approximately $89,000. FNY Investment Advisers LLC owned 0.20% of Firefly Neuroscience at the end of the most recent quarter. 4.96% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Firefly Neuroscience in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

About Firefly Neuroscience

Firefly Neuroscience, Inc, a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.